










T Assembly of Discrete Collagen–Chitosan 
Microenvironments into Multiphase Tissue Constructs 
 David J.  Caldwell ,  Rameshwar R.  Rao ,  and  Jan P.  Stegemann * IO
N We report on two novel methods of creating complex multi-
phase tissue constructs from discrete extracellular matrix 
microenvironments using centrifugation and vacuum molding. 
In general, the broad fi eld of tissue engineering encompasses a 
variety of methodologies for creating biological tissues for the 
replacement or repair of injured or diseased tissues. Modular 
tissue engineering attempts to create tissues by generating 
larger structures from repeating subunits, or “modules”. [ 1 ] These 
repeating subunits can be designed to have unique microarchi-
tectural features, and allow for the bottom-up creation of macro-
scale tissues. One advantage presented by the modular tissue 
engineering method is the ability to create complex tissues with 
precisely designed morphologies and spatially controlled pat-
terning. However, a current limitation of this technology is pro-
viding cells with appropriate functional extracellular matrices, 
which are critical for the development and differentiation of 
cells into desired tissue types. This paper presents facile tech-
niques by which modular microenvironments comprised of 
collagen-chitosan microbeads 200–300  μ m in diameter can 
be assembled into larger-scale constructs with defi ned spatial 
arrangement. Two methods are presented: vacuum molding 
and centrifugation. The ability to control the environment sur-
rounding cells in this manner allows for patterning of cellular 
microenvironments for the study of cell interactions, and this 
method may be extended to generation of complex tissues. 
 Assembly of cellular microenvironments into macroscopic, 
patterned, engineered tissues is a growing area of research. 
Previously explored methods include cell printing using jet-
based 3D printers, [ 2 ] self-assembly, [ 3 ] bioprinting, [ 4 ] robotic 
3D printing, [ 5 ] microtissue engineering, [ 6 ] and cell sheet engi-
neering. [ 7 ] The generation of shaped, multilayered tissues 
containing multiple cell types has applications in developing 
a wide a variety of complex tissues and organs, with the fi rst 
efforts being applied to generating vascularized bone tissue and 
osteochondral interfaces. [ 1 , 8 ] These efforts are progressing as 
new materials, assembly techniques and cell culture methods 
are developed. However, there is still a need for more robust 
approaches to the construction of three dimensional macro-
scale tissue constructs with defi ned architecture, and there is 
a particular challenge in creating these structures from physi-
ologically relevant extracellular matrix components. © 2013 WILEY-VCH Verlag G
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Adv. Healthcare Mater. 2013, 2, 673–677 Microscale hydrogels [ 9 ] and similar cellular microenviron-
ments have previously been used in the modular tissue engi-
neering approach. Our lab has created hydrogel “microbeads” 
comprised of cells embedded in spherical modules of defi ned 
extracellular matrix proteins and polysaccharides, including 
collagen, fi brin, agarose, and chitosan. [ 10–12 ] Chitosan and col-
lagen are of particular interest, as these naturally derived mate-
rials are both generally biodegradable and biocompatible, [ 13–15 ] 
and have been investigated for numerous applications in vas-
cular, [ 16 ] skin, [ 17 ] ligament, [ 18 ] and bone [ 19 ] tissue engineering. 
In general, the function of cells embedded within microbeads 
can be guided by defi ning the extracellular matrix composition, 
incorporating growth factors into the matrix, and by control-
ling the cell density and mechanical properties of the matrix. 
In addition, the properties of the microbeads themselves (den-
sity, stiffness, cohesiveness) can be modulated to control their 
assembly into larger scale structures. 
 In this study, microbeads were created from a composite 
of collagen Type I and chitosan using the process shown in 
 Figure  1 . To prepare microbeads, collagen and chitosan were 
mixed with culture medium, glyoxal, and beta-glycerophos-
phate ( β -GP) to create a 65/35 (mass ratio) collagen/chitosan 
embedding matrix. Glyoxal is a small aldehyde that is less cyto-
toxic than glutaraldehyde. [ 20 ]  β -GP was used to initiate gelation 
of chitosan/collagen matrix. [ 14 , 21 ] The liquid matrix solution was 
combined with cells or other components to be embedded, and 
the mixture was emulsifi ed in a rapidly stirred, ice-cold poly-
dimethylsiloxane (PDMS) bath. Emulsifi cation produced spher-
ical droplets 200–300  μ m in diameter, which were subsequently 
gelled into microbeads by raising the temperature (Figure  1 a). 
The gelled microbeads (Figures  1 b– 1 d) were collected and 
washed for use in experiments, and were shown to maintain 
the viability of embedded cells (Figures  1 e,  1 f). 
 The microbead matrix was also augmented at the time of 
emulsifi cation in selected experiments to facilitate assembly 
and visualization of macroscale constructs. Hydroxyapatite 
was added to certain microbead formulations to increase their 
density, and to thereby facilitate collection from the oil and 
subsequent use in centrifugation-based assembly. Hydroxya-
patite is the mineral component of bone and has been shown 
to promote osteogenic differentiation of progenitor cells. [ 22 ] 
Fluorescent microspheres were embedded in acellular con-
structs to allow visualization under visible and UV light. Cel-
lular constructs contained human fi broblasts cells genetically 
modifi ed to express green and red fl uorescent protein for 
visualization. 
 Centrifugation-based assembly of macroscale constructs 
was accomplished by adding concentrated suspensions of 
microbeads to a capped tubular container, and then centri-















 Figure  1 .  a) Schematic illustration of microbead fabrication process. b, c) Light microscopy images of 65–35 wt% collagen-chitosan microbeads (panel 
c show microbeads containing 2.5 mg/mL hydroxyapatite). d) Light microscopy of a population of collagen/chitosan microspheres showing their gener-
ally spheroidal morphology. e, f) Fluorescence microscopy of human mesenchymal stem cells embedded in 65–35 wt% collagen-chitosan microbeads 
at day 1 and day 7 of culture, respectively. The cytoplasm of living cells is stained green, and the nuclei of dead cells are stained red. centrifugally compacted constructs could then be extruded 
from the tube to create solid hydrogel plugs with the desired 
microbead distribution. Figure  2 a schematically shows an 
example of creating a 3-layer construct, and Figure  2 b shows 
an assembled 2-layer construct. The resulting multiphase con-
structs were cohesive, maintained their shape, and could be 
easily handled without disrupting their structure. Figure  2 c 
shows a two-phase construct being lifted with forceps, and 
constructs could be manipulated and transferred for fur-
ther processing. This method was used to create several lay-
ered architectures (imaged under fl uorescence in Figure  2 c), 
including single phase, two-phase with a discrete interface, 
two-phase mixed, and three-phase layered constructs. The 
centrifugation method of assembling constructs is simple and 
rapid, and has the advantage that it can be done in a closed 
system to preserve sterility. In addition, we have shown that it 
can be used to create mixed co-cultures and it may be useful in 
creating tissue interfaces. However, it is essentially limited to 
layered construct architectures. © 2013 WILEY-VCH Verlag Gwileyonlinelibrary.com4 Vacuum molding was also used to create multiphase 
microbead constructs, as shown in  Figure  3 . PDMS elastomer 
was used as a molding template because wells of the desired 
shape could be easily cut from this material, which is also bio-
logically inert and maintains its form after deformation. [ 23–25 ] 
Wells were constructed in a variety of shapes, including multi-
part disks, annular rings, as well as the Michigan “Block M” 
logo. A PDMS sheet containing these patterns was overlaid 
on a membrane fi lter with aspiration from below. To create 
constructs, microbeads were suspended in solution and then 
transferred into the molds with mild suction applied from 
below (Figure  3 a). Removal of the interstitial liquid between 
microbeads resulted in cohesive constructs that retained their 
shape upon removal from the wells. Multiphase constructs 
could be formed by sequential disassembly of the PDMS mold 
to fi ll in only the portions desired. 
 Constructs with various geometries were created using the 
vacuum molding method. Figure  3 B shows fl uorescently illumi-













 Figure  2 .  a) Schematic illustration of centrifugation method for construct assembly. b) Image 
of 2-layer construct created using blue microbeads and yellow microbeads with hydroxyapatite. 
c) Image of vacuum-molded multiphase construct being handled with forceps. d) Fluorescence 
imaging of single phase and layered multiphase constructs. Schematic shows intended pat-
tern of microbead distribution and mosaic reconstruction of fl uorescent images shows the 
construct created. and yellow microbeads. Pure phases could be easily assembled 
in patterns with discrete interfaces, in these examples either as 
pie-shaped wedges in a disk or as annular rings. Microbeads 
could also be combined into uniformly mixed composite phases, 
which in turn could be assembled with pure phases. Finally, a 
Block M logo was used to demonstrate the ability to create arbi-
trary patterns using the same molding technique. It should be 
noted that the patterns were not perfect, and displayed some 
distortion from the intended pattern. This variation is partially 
a result of imperfect addition of microbeads to the wells, as well 
as the “resolution” of the constructs, which was determined by 
the size of the microbeads (in this case 200–300  μ m). Layered 
constructs could also be made using this method by sequen-
tial addition of microbead preparations (Figure  3 c). In all cases, 
collagen-chitosan constructs were robust enough to be handled 
with forceps and could easily be cultured as cohesive 3D macro-
scale structures. 
 Fluorescently labeled, living fi broblast cells were also incor-
porated into microbeads and were patterned to create a gradient © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, WeinhAdv. Healthcare Mater. 2013, 2, 673–677across a 3D rectangular construct (Figure  3 d) 
by sequentially adding preparations with 
changing ratios of red and green cells. The 
cells remained viable over the 7 day culture 
period, showing that removal of interstitial 
fl uid in the constructs did not substantially 
harm the cells. The gradient produced was 
not ideal, but there was a clear and gradual 
shift in the predominance of red- or green-
labeled cells across the construct. Closer 
examination of the embedded cells (insets in 
Figure  3 d) showed that they were more elon-
gated at day 7, which suggests that the fi brob-
lasts were attached to and spread within the 
protein matrix. 
 The mechanical properties of the con-
structs depend on the interactions between 
the constituent microbeads. The collagen-
chitosan microenvironments used in the 
present study formed cohesive pastes in 
which microbeads presumably adhered to 
each other through electrostatic protein-
protein and/or protein-polysaccharide inter-
actions. The constructs created were cohe-
sive enough to be routinely handled and 
transferred using standard instruments, 
and their properties could be modulated 
by controlling the amount of water that 
was removed (data not shown). However, 
the desired mechanical properties will 
depend on the intended application, and 
different materials can be used to enhance 
or diminish interactions of the microbeads. 
Furthermore, multiphase tissues created 
using these techniques can be expected to 
mature under the appropriate conditions 
in vitro or in vivo, which will lead to matrix 
deposition, remodeling, and alteration of 
the mechanical properties. 
 Our studies have demonstrated that 
protein-polysaccharide microbeads can be assembled into 
larger-scale constructs with prescribed architecture. Centrifu-
gation-based assembly is facile and requires little handing of 
the microbeads, but is limited to layered geometries. Vacuum 
molding is also relatively simple and rapid, and allows more 
complex multiphase constructs to be assembled. The patterns 
that can be produced are limited only by the ability to create 
the appropriate molds, and we demonstrated millimeter scale 
resolution in these initial studies. Furthermore, we showed 
that microbeads support the viability of cells embedded within 
them, and that cells remain viable after assembly of larger-scale 
constructs. These methods may have applications in patterning 
of cells and microenvironments into tissue-like structures. Such 
models could be used to study cell-cell communication and the 
effects of defi ned co-cultures on cell function. In addition, the 
assembly of microenvironments into prescribed architectures 
could have utility in creating more complex engineered tissues, 
in which the spatial composition can be tailored to direct cell 















 Figure  3 .  (a) Annotated schematic illustration of vacuum molding method for construct 
assembly. b) Fluorescence imaging of patterned multiphase constructs using mixed and pure 
microbead preparations. Schematic shows intended pattern and mosaic reconstruction of fl uo-
rescent images shows the construct created. c) Images of layered constructs created using 
vacuum molding. d) Fluorescent imaging of graded microbead constructs containing red- and 
green-labeled fi broblast cells and day 1 and day 7 in culture. Schematic shows approximation 
of intended gradient across construct. Insets show higher magnifi cation view of embedded 
cells.  Experimental Section 
 Preparation of 65-35 Collagen-Collagen Microbeads: Collagen-chitosan 
microbeads were prepared using a water-in-oil emulsion procedure. 
Chitosan (2.0% wt/vol, dissolved in 0.1 N acetic acid) and Type I 
collagen (4.0 mg/mL dissolved in 0.02 N acetic acid) were mixed, and 
fl uorescent microspheres were added to facilitate visualization of the 
formed microbeads. Beta-glycerophosphate ( β -GP) and 1.0 mM glyoxal 
were mixed separately. A third solution of DMEM culture medium 
was also prepared, and contained the cellular component and/or the 
hydroxyapatite component, as appropriate for the desired microbead 
formulation. The fi broblasts were previously labeled using a retroviral 
expression system as previously described [ 26 ] and bead preparations 
were fabricated at 1.0  × 10 6 cells/mL. To fabricate microbeads, the 
three solutions were combined and the mixture was injected into 
a bath of ice-chilled liquid PDMS stirred using an impeller. Once © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinwileyonlinelibrary.com76the microbead matrix was fully emulsifi ed, the 
mixture was transferred to a 37  ° C water bath to 
induce co-gelation of the collagen and chitosan 
phases. Formed microbeads were separated from 
the oil phase by centrifugation and washing with 
phosphate buffered saline (PBS) supplemented 
with Pluronic L101 surfactant. 
 Assembly of 3D constructs by centrifugation: 
A 5 cm section of polyvinyl chloride (PVC) tubing 
with a 4 mm internal diameter and plugged at 
one end with a metal screw was used as a vessel 
to hold microbead preparations for centrifugation. 
Microbeads were injected directly into the tube 
using a micropipetter, and the tube was placed into 
a 15 mL centrifuge tube and centrifuged at 200g for 
5 minutes. For constructs with multiple layers, this 
procedure was performed multiple times to arrive 
at the desired geometry. The formed construct 
could then be extruded from the tubing by gently 
plunging using a 4 mm diameter rod. 
 Assembly of 3D constructs by vacuum molding: 
PDMS molds were prepared by mixing liquid 
PDMS (Sylgard) with curing agent in a 10:1 ratio 
by weight. The mixture was poured into Petri 
dishes and allowed to set for 2 days to achieve full 
solidifi cation, and was sterilized under UV light. 
Molding wells could be made either by putting a 
positive cast into the PDMS during curing, or by 
punching the desired shape out of the cured sheet. 
In this study, a Michigan Block M and rectangular 
casts were used for positive casting, and circular 
wells were made using biopsy punches. For creating 
multiphase constructs, portions of the PDMS were 
removed from the wells sequentially as microbead 
preparations were added. In order to create 3D 
constructs, the PDMS mold was placed on top of 
a 0.22  μ m fi lter, and a vacuum was pulled through 
the fi lter. Microbeads suspended in PBS were 
injected into the mold with a micropipette and the 
interstitial liquid was aspirated to waste. 
 For microbeads containing cells, red and green 
fl uorescently labeled human fi broblasts were grown 
in culture and then embedded in the microbeads 
during fabrication. The 3D macroscale constructs 
produced from the cell-laden microbeads were 
cultured in fi broblast cell medium in a 37  ° C 
incubator, with medium changes every two days. 
Images of microbeads and constructs were 
taken either by visible light microscopy or using 
fl uorescence microscopy. Macroscale fl uorescence 
images visualized the embedded fl uorescent 
microspheres, whereas laser scanning confocal microscopy was used to image inside the cell-laded constructs to 
visualize the cells. Image processing was performed in ImageJ. 
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